» Articles » PMID: 25922442

24,25-Dihydroxyvitamin D3 and Vitamin D Status of Community-dwelling Black and White Americans

Overview
Journal Clin Chem
Specialty Biochemistry
Date 2015 Apr 30
PMID 25922442
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: 24,25-Dihydroxyvitamin D [24,25(OH)2D] is a metabolite of 25-hydroxyvitamin D (25D). Blacks frequently have low total 25D without manifestations of vitamin D deficiency, suggesting that total serum 25D may incorrectly reflect vitamin D status in different racial groups. The ratio of serum 24,25(OH)2D to 25D [vitamin D metabolite ratio (VMR)] represents a new candidate biomarker for vitamin D status.

Methods: We measured 24,25(OH)2D3 and 25D3 by mass spectrometry in a random community cohort of black (n = 212) and white (n = 164) Americans to evaluate VMR as a marker for vitamin D status. We measured parathyroid hormone concentrations by immunoassay to compare VMR and 25D3 against a physiological indicator of vitamin D deficiency.

Results: Serum 24,25(OH)2D3 strongly correlated with 25D3 in both black and white study participants (r = 0.90, P < 0.001 and r = 0.86, P < 0.001 respectively). Blacks had lower mean 25D3 than whites [17.0 (7.8) vs 27.5 (11.3) ng/mL; 42.4 (19.5) vs 68.6 (28.2) nmol/L, P < 0.001] and lower mean 24,25(OH)2D3 [2.1 (1.3) vs 3.6 (2.0) ng/mL; 5.1 (3.1) vs 8.7 (4.8) nmol/L, P < 0.001]. In contrast to total 25D3 concentrations, mean VMR values were similar in blacks and whites [11.9 (4.0) vs 12.5 (3.4), P = 0.16, respectively] and were negatively correlated with parathyroid hormone concentrations in both races (rs = -0.26, P < 0.001, and rs = -0.25, P < 0.001, respectively).

Conclusions: Our results provide further evidence that measurement of total 25D for assessment of vitamin D status in patients of African descent deserves reevaluation and suggest that alternative measures such as VMR should be considered.

Citing Articles

Assessment of Vitamin D Metabolism Disorders in Hemodialysis Patients.

Hryciuk M, Heleniak Z, Malgorzewicz S, Kowalski K, Antosiewicz J, Koelmer A Nutrients. 2025; 17(5).

PMID: 40077644 PMC: 11901569. DOI: 10.3390/nu17050774.


Investigation of the Vitamin D Metabolite Ratio (VMR) as a Marker of Functional Vitamin D Deficiency: Findings from the SarcoPhAge Cohort.

Ladang A, Gendebien A, Kovacs S, Demonceau C, Beaudart C, Peeters S Nutrients. 2024; 16(19).

PMID: 39408192 PMC: 11478400. DOI: 10.3390/nu16193224.


An ultra-sensitive and high-throughput trapping-micro-LC-MS method for quantification of circulating vitamin D metabolites and application in multiple sclerosis patients.

Qu F, Zhang M, Weinstock-Guttman B, Zivadinov R, Qu J, Zhu X Sci Rep. 2024; 14(1):5545.

PMID: 38448553 PMC: 10918069. DOI: 10.1038/s41598-024-55939-0.


Multicenter comparison of analytical interferences of 25-OH vitamin D immunoassay and mass spectrometry methods by endogenous interferents and cross-reactivity with 3-epi-25-OH-vitamin D.

Lee J, Seo J, Lee K, Roh E, Yun Y, Lee Y Pract Lab Med. 2024; 38:e00347.

PMID: 38188654 PMC: 10770599. DOI: 10.1016/j.plabm.2023.e00347.


Seasonal changes in free 25-(OH)D and vitamin D metabolite ratios and their relationship with psychophysical stress markers in male professional football players.

Ksiazek A, Zagrodna A, Lombardi G, Slowinska-Lisowska M Front Physiol. 2023; 14:1258678.

PMID: 37908338 PMC: 10613696. DOI: 10.3389/fphys.2023.1258678.


References
1.
Powe C, Evans M, Wenger J, Zonderman A, Berg A, Nalls M . Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369(21):1991-2000. PMC: 4030388. DOI: 10.1056/NEJMoa1306357. View

2.
Trummer O, Pilz S, Hoffmann M, Winkelmann B, Boehm B, Marz W . Vitamin D and mortality: a Mendelian randomization study. Clin Chem. 2013; 59(5):793-7. DOI: 10.1373/clinchem.2012.193185. View

3.
Johnsen M, Grimnes G, Figenschau Y, Torjesen P, Almas B, Jorde R . Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D. Scand J Clin Lab Invest. 2014; 74(3):177-83. DOI: 10.3109/00365513.2013.869701. View

4.
Carter G, Phinney K . Assessing vitamin D status: time for a rethink?. Clin Chem. 2014; 60(6):809-11. DOI: 10.1373/clinchem.2013.219386. View

5.
Kaufmann M, Gallagher J, Peacock M, Schlingmann K, Konrad M, Deluca H . Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab. 2014; 99(7):2567-74. PMC: 4079315. DOI: 10.1210/jc.2013-4388. View